Related Experiment Video
Updated: Jul 10, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Cost Analysis for Home and Home-Assisted Renal Replacement Therapy Compared to In-Centre Hemodialysis
Lorenzo Aterini1, Gian Marco Caselli1, Costanza Gaudio1
1SOC Nefrologia e Dialisi, Ospedale San Giovanni di Dio, Dipartimento Specialità Mediche, Azienda USL Toscana Centro, Firenze, Italy.
Insights
Home dialysis therapies, including assisted options, are more cost-effective than in-centre hemodialysis. This study highlights the economic viability of expanding home dialysis programs for chronic kidney disease patients.
Area of Science:
- Nephrology
- Health Economics
- Renal Replacement Therapy
Background:
- Chronic kidney disease (CKD) is a widespread condition necessitating dialysis, with facility-based hemodialysis being the most common treatment modality.
- Understanding the cost implications of various dialysis modalities is crucial for healthcare system planning and resource allocation.
Purpose of the Study:
- To estimate and compare the costs of in-centre hemodialysis/hemodiafiltration with home-based peritoneal dialysis and home hemodialysis.
- To evaluate the cost-effectiveness of dialysis treatments, with or without healthcare staff assistance.
Main Methods:
- A cost analysis was performed at a hospital in Florence, Italy, examining high- and low-flux bicarbonate hemodialysis (HD), hemodiafiltration (HDF), automated peritoneal dialysis (APD), continuous ambulatory peritoneal dialysis (CAPD), and daily home HD.
- Monthly costs were calculated, encompassing direct medical expenses, indirect costs, personnel expenses, and patient transportation.
Main Results:
- In-centre hemodialysis and hemodiafiltration incurred monthly costs of €4672 and €4766, respectively.
- Home-based peritoneal dialysis (CAPD and APD) ranged from €1613 to €4454 monthly, depending on healthcare assistance.
- Home hemodialysis costs were €2225 monthly without assistance and €4049 with assistance.
Conclusions:
- Home-based dialysis modalities, including assisted treatments, present a more cost-competitive alternative to in-centre hemodialysis.
- The findings suggest that expanding home dialysis programs is economically sustainable within the current healthcare framework.
Abstract:
Introduction. Chronic kidney disease (CKD) is a prevalent condition which may require dialysis; the most common form of this is facility-based haemodialysis. This study aims to provide cost estimates for in-centre haemodialysis/haemodiafiltration compared with home-based peritoneal dialysis and haemodialysis, with or without healthcare staff assistance. Methods. A cost analysis was conducted at the Nephrology and Dialysis Units of San Giovanni di Dio Hospital (Florence, Italy) for the following procedures: high- and low-flux bicarbonate HD (39.95.4), HDF (39.95.7), APD (54.98.1), CAPD (54.98.2), and daily home HD for at least 12 hours/week (39.95.O). Costs were calculated on a monthly basis and included direct medical costs, indirect costs, healthcare personnel costs, and patient transportation costs. Results. In-centre bicarbonate hemodialysis and hemodiafiltration showed a monthly cost of €4672 and €4766, respectively. CAPD and APD monthly costs were €1613 and €2080 without, and €4454 and €3774, respectively, with healthcare assistance. Home hemodialysis monthly costs were €2225 and €4049 in case of healthcare assistance. Discussion. Home-based dialysis modalities, including assisted treatments, demonstrated overall cost competitiveness compared with in-centre hemodialysis. These findings support the potential economic sustainability of expanding home dialysis programs within the healthcare system.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Hemodialysis III: Nursing Management
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis